Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X ...

Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene ...

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...

Standard BioTools (NASDAQ:LAB) shares jumped as much as 19% premarket on Monday after the company announced the sale of its SomaLogic business to Illumina (NASDAQ:ILMN) for an aggregate cash ...

Li Qing (left), senior vice-president of Illumina and general manager the company's China operation, shows reporters around the company's newly launched manufacturing site in Shanghai. [Photo provided ...

A novel device involving the cell lysis and DNA amplification performed in a single step have been proposed by Ke et al. (2007). A simple and rapid protocol for the preparation of total genomic DNA ...